Cairo, Egypt : Altibbi, the Middle East’s first and largest digital health platform, announces a new method of consultations in Egypt, designed to provide instant, easy and affordable access to healthcare.
Egyptians can dial 1130 and connect with a certified doctor directly. Payment is taken via phone credit per minute.
By enabling those without a smartphone or internet connection to access healthcare services, Altibbi is extending healthcare coverage to a wider audience in Egypt. Altibbi is committed to delivering quality healthcare services for all and reducing inequalities in access – particularly pertinent in Egypt given the complexity of its healthcare system due to social and economic challenges.
The hotline is available anywhere in Egypt and Altibbi’s aim is to provide 2 million consultations in Egypt by the end of Q2 2022.
This initiative builds on Altibbi’s partnership with the Egyptian and Jordanian governments to provide its telehealth services through the respective national Covid-19 hotlines. These were vital in easing the pressure on the national healthcare systems, connecting users to certified doctors and combating the transmission of the coronavirus.
Jalil Allabadi, founder & CEO of Altibbi, said:
“We are excited to announce Altibbi’s new hotline service. With Egypt representing one of our key markets, we wanted to address the gaps in its complex healthcare system and this initiative does just that. By providing a simple hotline service, accessible to all, Altibbi is enabling fast, easy and affordable access to healthcare services throughout the nation. It represents another important step in our efforts to delivering quality healthcare services for all in the region.”
Founded in 2011, Altibbi has grown to become the largest digital health provider in the Arab world with +2 million pages of content, 24/7 Telehealth service in seven Arab countries and +500,000 daily users. In 2020 alone, the Company delivered healthcare services to over 300 million patients worldwide, expanded its services to 12 countries and created job opportunities for 60,000 doctors around the region.
This major 1130 hotline follows the launch of Altibbi’s medical academy in October 2021, aimed at strengthening virtual pharmacy care across the Middle East. All the courses are certified by the Royal College of General Practitioners in the UK and delivered through a partnership with Primary Care International. All 1,500 Altibbi doctors will be enrolled by the end of 2022.
-Ends-
Further information
Thoburns
Jamie Pudge
j.pudge@thoburns.com
+447557771703
About Altibbi
Altibbi is the first platform in the Arab world to provide a remote medical consultation service and allow patients to communicate with accredited doctors directly by phone call or text chat.
Altibbi works also on more than a million pages of Arab medical content over the Internet, providing reliable medical information to those who need it, in addition to providing medical consultations via the Internet in all countries of the Arab world.
400 million people in the Arab world lack basic health services, including access to medical information and advice, as over 70% of doctors' visits are unnecessary and add to the burden on the health system.
Altibbi is the largest Arab medical platform that deals with providing reliable medical content, which had been accredited by 10 thousand well known doctor to the Arab readers, and Altibbi’s website won the World Summit Award for Best Digital Health Content and the Schwab Award for Best Social Institution.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
